MedTrace Logo

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

NCT04080596 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-09-06

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin.

Conditions

  • Drug Interaction

Interventions

DRUG

Dorzagliatin

GKA for T2DM currently under clinical development

Sponsors & Collaborators

  • Hua Medicine Limited

    lead INDUSTRY

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-13
Primary Completion
2017-12-05
Completion
2017-12-05
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04080596 on ClinicalTrials.gov